Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
olanzapine, Quantity: 2.5 mg
Medis Pharma Pty Ltd
Olanzapine
Tablet, film coated
Excipient Ingredients: hyprolose; magnesium stearate; microcrystalline cellulose; crospovidone; lactose monohydrate; purified talc; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin
Oral
50, 40, 21, 14, 60, 28, 10, 30, 7, 20
(S4) Prescription Only Medicine
For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.
Visual Identification: White, round, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2011-08-11